Day: June 4, 2021

Microbot Medical Secures Additional Protection for the One & Done Guidewire Technology with another Notice of Patent Allowance

Written by Customer Service on June 4, 2021. Posted in Public Companies.

HINGHAM, Mass., June 04, 2021 (GLOBE NEWSWIRE) — Global patent jurisdictions continue to recognize Microbot Medical Inc.’s (Nasdaq: MBOT) innovative ‘One & Done’ guidewire technology, as the Israel Intellectual Property Office has issued a Notice of Allowance (NOA). The allowed application covers Microbot’s double guidewire technology that has been granted in Europe, Japan and now Israel. Globally, Microbot Medical holds a total of 42 patents issued/allowed and 23 pending patent applications. “The One & Done is an integral part of the future development portfolio of LIBERTY, and will ensure we maintain sustainable competitive advantage,” commented Harel Gadot, CEO, President and Chairman. “We are very pleased that our continued focus on innovation is reflected in our differentiated technology IP portfolio that has been...

Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting

Written by Customer Service on June 4, 2021. Posted in Public Companies.

8 of 11 Patients in Dose Escalation Cohorts 2 and 3 Achieved Objective Response 6 of 11 Patients Achieved Complete Response, including 2 Patients Previously Treated with Autologous CD19 CAR T-cell Therapy Favorable FT516 Safety Profile Was Observed; No FT516-related Serious Adverse Events or FT516-related Grade 3 or Greater Adverse Events Outpatient Treatment Regimen Was Well-tolerated; No Events of Any Grade of Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, or Graft-vs-Host Disease SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today highlighted positive interim Phase 1 data from the Company’s FT516 program for patients with relapsed...

Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular Carcinoma

Written by Customer Service on June 4, 2021. Posted in Public Companies.

CAMBRIDGE, Mass., June 04, 2021 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced a clinical trial collaboration with Roche to evaluate SRF388, Surface’s investigational anti-IL-27 antibody, in combination with Roche’s atezolizumab and bevacizumab in patients with treatment-naïve hepatocellular carcinoma (HCC). Atezolizumab plus bevacizumab has been shown to significantly improve overall survival and, as reflected in many global clinical practice guidelines, is the new standard of care for unresectable or metastatic HCC. Evolving preclinical and epidemiologic data suggest a significant role for the immunosuppressive cytokine IL-27 in HCC and in resistance to PD-1 pathway blockade. Therefore,...

Goodfood’s Active Subscribers Count Increases 17% Year-Over-Year to Reach 317,000

Written by Customer Service on June 4, 2021. Posted in Public Companies.

MONTREAL, June 04, 2021 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading online grocery company in Canada, announced today it had 317,000 active subscribers at the end of the third quarter of Fiscal 2021. This represents an increase of 17% compared to the same period last year. “We are pleased with our year-to-date active subscriber growth, although we experienced a small quarter-to-quarter decline of 2,000 active subscribers, or 0.6%, that we believe was driven in part by unseasonably warm weather and the effect of re-opening in many provinces. We remain very pleased with the strong subscriber order rates and basket sizes which are to a large extent being driven by our ever-increasing selection of grocery items. Together, these metrics position Goodfood very well towards achieving...

Mega Uranium Announces Further Investments in Toro Energy Ltd. and International Consolidated Uranium Inc.

Written by Customer Service on June 4, 2021. Posted in Public Companies.

TORONTO, June 04, 2021 (GLOBE NEWSWIRE) — Mega Uranium Ltd. (MGA: TSX) is pleased to announce that it has participated in the recently closed equity financings of Toro Energy Limited (ASX: TOE; “Toro Energy”) and International Consolidated Uranium Inc. (TSXV: CUR; “Consolidated Uranium”), two publicly-listed issuers engaged in uranium exploration and development activities. Mega’s AUD$1.5M investment in Toro Energy formed part of Toro Energy’s AUD$15M aggregate equity financing, that, together with and subject to completion of its proposed AUD$6.7M debt conversion transaction (which requires shareholder approval), would position Toro Energy as debt-free and well-funded for its ongoing development and exploration programs. Mega has been a long-time shareholder and supporter of Toro Energy dating back to 2013 and now holds a 12.76%...

BeyondSpring Announces First Patient Dosed in a Triple Combination Study with Plinabulin, PD-1/PD-L1 Inhibitor and Radiotherapy for the Reversal of Resistance to PD-1/PD-L1 Inhibitors in Patients with Advanced Solid Tumors

Written by Customer Service on June 4, 2021. Posted in Public Companies.

Resistance to immunotherapy is a severe unmet medical need that plinabulin aims to address in combination with checkpoint inhibitors and radiotherapy First patient who failed Keytruda and chemotherapy has been dosed with plinabulin, Keytruda and radiation combination in non-small cell lung cancer (NSCLC)NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) — BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the first patient had been dosed in the Phase 1b/2 investigator-initiated trial, studying the safety and tolerability of plinabulin, in triple combination therapy with both PD-1/PD-L1 antibody (mAb) and radiation therapy (RT). This triple combination is actively recruiting at The University of Texas MD Anderson...

Chart Industries Invests in and Signs Commercial Memorandum of Understanding with Small-Scale Carbon Capture Company, Earthly Labs

Written by Customer Service on June 4, 2021. Posted in Public Companies.

ATLANTA, June 04, 2021 (GLOBE NEWSWIRE) — Chart Industries, Inc. (“Chart”) (NYSE: GTLS), a leading global manufacturer of liquefaction and cryogenic equipment serving multiple applications in the energy and industrial gas end markets, including carbon capture, today announced the completion of a minority investment in Earthly Labs, Inc. (“Earthly Labs”) for the amount of $5 million and a commercial Memorandum of Understanding (“MOU”). Earthly Labs is the leading provider of small-scale carbon capture systems offering an affordable, small footprint technology platform called “CiCi ®” to capture, recycle, reuse, track and sell CO2. Earthly Labs proprietary approach includes hardware, software and services to address half of all existing carbon dioxide emissions from industrial sources while converting molecules to value. Chart’s...

Bunker Hill Mining Announces Filing of PEA Technical Report

Written by Customer Service on June 4, 2021. Posted in Public Companies.

TORONTO, June 04, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR) is pleased to announce filing of an independent Preliminary Economic Assessment (“PEA”) for the Bunker Hill Mine in the world-class Silver Valley region of Idaho, USA. The report, dated June 4, 2021 and entitled, “NI 43-101 Technical Report and Preliminary Economic Assessment of the Bunker Hill Mine”, was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”). Bunker Hill’s news release dated April 20, 2021 (entitled “Bunker Hill Announces Robust Restart PEA: $101M NPV, 46% IRR, 2.5 Year Payback, $42M Initial Capex, $20M Average Annual FCF Over 10 Years”) summarizes key results, assumptions and estimates contained in the PEA. The Company is pleased to...

Gran Colombia Completes Arrangement with Gold X for the Creation of a New Mid-Tier Latin American Gold Producer

Written by Customer Service on June 4, 2021. Posted in Mergers And Acquisitions.

TORONTO, June 04, 2021 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) (“Gran Colombia”) announced today the completion of its acquisition of all of the issued and outstanding common shares (the “Gold X Shares”) of Gold X Mining Corp. (TSXV: GLDX) (“Gold X”) not already owned by Gran Colombia by way of a statutory plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia). The Arrangement became effective at 12:01 a.m. (Pacific Time) on June 4, 2021 (the “Effective Time”). As a result of the Arrangement, Gold X became a direct, wholly-owned subsidiary of Gran Colombia and Gran Colombia gained control of the Toroparu Gold Project located in Guyana, South America. Serafino Iacono, Executive Chairman of Gran Colombia, commented: “With the closing of the Gold X acquisition today,...

Versus Systems Closes Acquisition of Xcite Interactive

Written by Customer Service on June 4, 2021. Posted in Mergers And Acquisitions.

Versus to add prizing to TV, streaming, dozens of NFL, MLB, NHL, and other fan experiences LOS ANGELES, June 04, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) (FRANKFURT: BMVB) announced today the completion of its previously announced acquisition of Xcite Interactive, Inc. (“Xcite”). The acquisition was completed through a merger of a wholly-owned subsidiary of Versus with and into Xcite. Versus will add its proprietary prizing engine to Xcite’s newly developed XEO platform that is already in use with multiple professional sports teams and live major events. This rewards-based engagement will expand into TV and streaming while capitalizing on Xcite’s connections with more than 150 sports teams and brands. The new Versus-XEO platform will allow fans to interact with their favorite shows, games,...

Day: June 4, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals